These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6384571)

  • 21. The effect of prolonged vasopressin administration on the level and metabolism of catecholamines in the rat brain and kidneys.
    Szmigielska H
    Acta Physiol Pol; 1976; 27(3):259-64. PubMed ID: 7918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for inhibition of dopamine-beta-hydroxylase in vivo after sub-acute pyrazole treatment in rats.
    MacDonald E; Pispa JP
    Med Biol; 1977 Oct; 55(5):284-91. PubMed ID: 22792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Schizophrenia and cerebral amines].
    Véron JP; Kezirian S
    Presse Med (1893); 1971 Oct; 79(44):1973-4. PubMed ID: 5119550
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical studies in schizophrenia.
    Thakar J
    Psychiatr J Univ Ott; 1983 Jun; 8(2):44-50. PubMed ID: 6137016
    [No Abstract]   [Full Text] [Related]  

  • 25. Derivatization chemistries for determination of serotonin, norepinephrine and dopamine in brain microdialysis samples by liquid chromatography with fluorescence detection.
    Yoshitake T; Kehr J; Todoroki K; Nohta H; Yamaguchi M
    Biomed Chromatogr; 2006 Mar; 20(3):267-81. PubMed ID: 16110472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modifications of cerebral amine metabolism in psychiatric illness].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses.
    Davis JM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():333-46. PubMed ID: 3830
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of alpha, alpha1-dipyridyl on noradrenaline, dopamine and 5-hydroxytryptamine levels and on dopamine-beta-hydroxylase activity in brain.
    Mogilnicka E; Szmigielski A; Niewiadomska A
    Pol J Pharmacol Pharm; 1975; 27(6):619-24. PubMed ID: 1715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physiopathologic chemistry of the schizophrenic brain].
    Shohmori T; Morimasa T
    Nihon Rinsho; 1987 Sep; 45(9):2105-13. PubMed ID: 2892954
    [No Abstract]   [Full Text] [Related]  

  • 30. The catecholaminergic system of the quail brain: immunocytochemical studies of dopamine beta-hydroxylase and tyrosine hydroxylase.
    Bailhache T; Balthazart J
    J Comp Neurol; 1993 Mar; 329(2):230-56. PubMed ID: 8095939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Amines in mental disorders (author's transl)].
    Takahashi R
    Tanpakushitsu Kakusan Koso; 1977; 22(6):815-21. PubMed ID: 337391
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the functional role of intraneuronal monamine oxidase.
    Clarke DE; Sampath SS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):539-49. PubMed ID: 4770399
    [No Abstract]   [Full Text] [Related]  

  • 33. Monoamine oxidase, phenylethylamine, norepinephrine and schizophrenia.
    Wyatt RJ; Karoum F; Stoff DM; Kleinman JE; Gillin JC; Jeste DV; Potkin SG
    Clin Genet; 1981 May; 19(5):437-42. PubMed ID: 7296934
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress.
    Bliss EL; Ailion J; Zwanziger J
    J Pharmacol Exp Ther; 1968 Nov; 164(1):122-34. PubMed ID: 4387046
    [No Abstract]   [Full Text] [Related]  

  • 35. [Brain of patients with chronic schizophrenia and neurotransmitters].
    Toru M
    Seishin Shinkeigaku Zasshi; 2005; 107(10):1015-21. PubMed ID: 16381382
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenergic neurotransmitter storage and release.
    Von Euler US
    Hawaii Med J; 1974 Oct; 33(10):371-5. PubMed ID: 4376551
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of variations in adrenocortical function on dopamine beta-hydroxylase and norepinephrine in the brain of the rat.
    Shen JT; Ganong WF
    J Pharmacol Exp Ther; 1976 Dec; 199(3):639-48. PubMed ID: 994021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Oct; 46(10):564-77. PubMed ID: 29831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relation among plasma dopamine beta-hydroxylase, monoamine oxidase and Cu++].
    Stagni S; Mello P; Gualandi S; Guidi M; Illuminati B; Scanabissi E
    Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1603-6. PubMed ID: 7459081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon disulfide. II. A proposed mechanism for the action of carbon disulfide on dopamine beta-hydroxylase.
    McKenna MJ; DiStefano V
    J Pharmacol Exp Ther; 1977 Aug; 202(2):253-66. PubMed ID: 886465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.